|
To truly understand the limitations of CMI, consider these examples. These MSDRG have the same
case weight but extremely different supply costs.
|
MSDRG |
Description |
Case Weight |
National Average Supply Cost |
|
484. |
Major Joint & Limb Reattachment Procedures of Upper
Extremity without CC/MCC |
1.74 |
$5,929 |
|
199 |
Pneumothorax w MCC |
1.74 |
$1,457 |
|
36 |
Carotid Artery Stent Px w/o CC/MCC |
1.57 |
$5,027 |
|
58 |
Multiple Sclerosis & Cerebellar Ataxia w MCC |
1.57 |
$1,266 |
What has been lacking from CMI, as well as other traditional methods of benchmarking supply
expense, is a methodology that (a) allows an evaluation of supply expense based on the specific
cases at a particular hospital and (b) allows for ongoing evaluation of a hospital’s supply expense
relative to the changes in a hospital’s patient population. Without this information, hospitals are often
comparing “apples to oranges” when trying to benchmark and are unable to successfully measure
performance on an ongoing basis.
One proven methodology to help providers understand if their supply spend is appropriate is the
Supply Intensity Metric or SIM
SIM is different from traditional supply expense performance metrics because it reflects the supply
intensity of a patient population, which does not always correlate with the clinical severity or highlevel
resource utilization that are parts of the traditional methods of looking at supply costs. It does
this by targeting a hospital’s projected supply expenses based on the actual mix of patients seen and
procedures performed. It then compares a hospital’s overall supply expense profile to that of similar
facilities to gauge cost performance versus best practice.
SIM answers key questions for hospitals, such as:
-
“Supply expense is increasing, but so are the number of patients treated. Given these changes,
how well are we managing our supply expenses?”
-
“What should my supply spend be given the numbers and types of patients I treat?”
-
“How do we compare to other similar facilities?”
-
“What patient populations should I focus on for supply cost reductions?”
Once SIM has created a metric to indicate the “supply intensity” of a facility, that metric is then used
to create better benchmark groups. In addition, the same standard supply costs per DRG that are
used to calculate the SIM are used to calculate a target total supply spend for the facility:
-
Target inpatient supply costs are based on the actual annual number of DRGs at a particular
facility and the standard supply cost per DRG.
-
Outpatient supply costs are estimated from total supply costs and the ratio of inpatient and
outpatient revenue.
-
Non-chargeable supply costs are either taken from the general ledger or predicted based on the
number of patient days and a target cost-per-patient day also developed from experience.
Supply expense is increasing, but the gap between Supply Expense and SIM targets
is decreasing.

Using insights from SIM, a hospital can observe changes in supply expense over time that would
result from changes in supply intensity, such as increases in the number of total joint replacements
or oncology admissions involving expensive chemotherapy, and decreases in the number of lesssupply-
intensive medical patients, such as deliveries. Ultimately, SIM can help hospitals to identify
opportunities for better cost management – a key imperative in today’s hospital environment.
SIM provides the data to more effectively measure supply expense and drive positive change in
hospitals. Several health systems have realized the benefit of having a reliable information tool to
guide and measure their supply expenses:
Inova Health System serves more than one million people in Northern Virginia. Its Inova Joint
Replacement Center, a Center of Excellence at Inova Mount Vernon Hospital, performs more than
1500 procedures annually. When comparing Mount Vernon to similar-sized facilities and to its sister
campuses using traditional metrics, a hospital administrator might think Inova Mount Vernon Hospital
has abnormally high supply costs. But Cindy Kilgore, Inova’s vice president of supply chain, says the
SIM analysis showed that Inova Mount Vernon’s overall supply costs were in line with best practice
supply costs given the large number of total joint patients treated at the hospital. “SIM was the first
benchmark that actually made sense given the joint program at Mount Vernon.” SIM reveals that
Mount Vernon is not an outlier, but is controlling supply costs for its specific patient population.
Atlantic Health, a $1 billion dollar healthcare system in New Jersey, used the SIM methodology to
determine the root cause of increasing supply costs. Supply expense was up 5% from the prior six
months, but inpatient discharges were flat and adjusted discharges were down. Clearly supply costs
were out of control. Or were they? Traditional supply expense metrics provided conflicting answers.
Atlantic Health’s chief supply chain officer, Joe DiPaolo, knew that significant changes in their patient
mix were an important part of the equation, but he was having difficulty finding answers and justifying
the supply expense increases.
A year prior, Overlook Hospital, one of the two Atlantic facilities, had absorbed additional total joint,
spine, cardiac, and interventional volume when a neighboring hospital closed. Since then these
programs have continued to grow. Meanwhile, Morristown Memorial Hospital has also continued to
grow, but in different ways. The new Gagnon Heart Hospital was opened in January 2009. These
changes were coupled with decreases in women’s and children’s patients as well as behavioral
health and general medical patients.
The types of shifts in patient mix that Atlantic Health is managing are very challenging for a supply
chain team: new technology, new physicians, and new vendors. Monitoring supply expense versus
SIM targets demonstrated that the supply expense increases observed were not out of line. While
the entire supply expense increase could not be explained by the changes in Atlantic Health’s patient
population, for the first time, Atlantic can understand the impact of this factor. Armed with this
information, DiPaolo helped the supply chain team and hospital leadership to understand that the
supply expense increase is not a crisis. This approach also allows DiPaolo’s team to focus on these
populations going forward to maintain good cost management.
Michael Louviere says SIM has become an important component of the supply chain department’s
process to consistently review and improve on its activities in order to support the health system
overall. SIM serves as his department’s own barometer, providing quarterly insight into whether the
hospital’s supply expenses are in line or if they need to review expenses more closely. SIM is key to
effectively measuring, and thereby controlling supply expenses in a constantly changing
environment.
As hospitals strive to drive operational improvements and cut costs, gaining a more accurate picture
of supply costs is a critical step. With falling margins, every dollar counts, and effective utilization of
resources—both in supplies and the personnel who manage them—is imperative. SIM is an answer
for supply chain leaders seeking new tools to meet new challenges.
It is crucial that health systems get it right when predicting supply costs – for the benefit of their
organizations and communities.
Lisa Dietz serves as Director, Aspen Healthcare Metrics, a MedAssets Company and is a Six Sigma
Black Belt.
|